Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Immunotherapy: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | Immunotherapy |
| Key Genes/Proteins | AGING, AIM2, AKT, ALPHA-SYNUCLEIN, ALZHEIMER, ALZHEIMER DISEASE |
| Related Diseases | Aging, Als, Alzheimer, Alzheimer'S Disease |
| Linked Hypotheses | 2 hypotheses |
Knowledge base pages for this entity
graph TD
Immunotherapy["Immunotherapy"]
Glioblastoma_Multiforme{"Glioblastoma Multiforme"}
Immunotherapy -->|"treats"| Glioblastoma_Multiforme
GENES(["GENES"])
GENES -->|"therapeutic_target"| Immunotherapy
CANCER(["CANCER"])
CANCER -->|"therapeutic_target"| Immunotherapy
Cancer{"Cancer"}
Cancer -->|"therapeutic_target"| Immunotherapy
INFLAMMATION(["INFLAMMATION"])
INFLAMMATION -->|"therapeutic_target"| Immunotherapy
style Immunotherapy fill:#1a3a4a,stroke:#90a4ae,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Non-Small Cell Lung Cancer | treats | disease | 0.90 |
| Digestive System Cancers | treats | disease | 0.90 |
| Digestive Cancers | treats | disease | 0.90 |
| Tumor Cell Death | mediates | phenotype | 0.85 |
| Oxidative Stress-Targeting Approaches | interacts_with | mechanism | 0.85 |
| Tumor Cell Death | associated_with | phenotype | 0.85 |
| Anti-Tumor Response | promotes | process | 0.85 |
| ischemic stroke | causes | disease | 0.80 |
| Glioblastoma | treats | disease | 0.80 |
| NEURODEGENERATIVE DISEASES | treats | disease | 0.80 |
| Glioblastoma Multiforme | treats | disease | 0.75 |
| Alzheimer's disease | treats | disease | 0.70 |
| B CELLS | activates | concept | 0.50 |
| cGAS-STING pathway | activates | pathway | 0.50 |
| PD-L1 | activates | concept | 0.50 |
| ISCHEMIC STROKE | activates | concept | 0.50 |
| PD-L1 | associated_with | concept | 0.50 |
| Immune Checkpoint | associated_with | pathway | 0.50 |
| Immune Checkpoint | inhibits | pathway | 0.50 |
| PD-L1 | expressed_in | concept | 0.50 |
| CYTOKINE | associated_with | concept | 0.50 |
| CHRONIC INFLAMMATION | associated_with | concept | 0.50 |
| Cognitive Decline | associated_with | disease | 0.50 |
| AMYLOID-β | associated_with | concept | 0.50 |
| Prostate Cancer | activates | disease | 0.50 |
| PD-L1 | inhibits | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PI3K | therapeutic_target | gene | 1.00 |
| Cancer | activates | disease | 1.00 |
| GENES | therapeutic_target | gene | 1.00 |
| MTOR | therapeutic_target | gene | 1.00 |
| CANCER | activates | gene | 1.00 |
| Tumor | activates | disease | 1.00 |
| AKT | therapeutic_target | gene | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| Tumor | associated_with | disease | 1.00 |
| TP53 | therapeutic_target | gene | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| APOPTOSIS | therapeutic_target | gene | 1.00 |
| Colorectal Cancer | therapeutic_target | disease | 1.00 |
| INFLAMMATION | therapeutic_target | gene | 1.00 |
| CYTOKINES | therapeutic_target | gene | 1.00 |
| AUTOPHAGY | therapeutic_target | gene | 1.00 |
| Tumor | regulates | disease | 1.00 |
| Inflammation | therapeutic_target | disease | 1.00 |
| Cancer | inhibits | disease | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| DNA | therapeutic_target | gene | 1.00 |
| Als | inhibits | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| CANCER | inhibits | gene | 1.00 |
| Tumor | inhibits | disease | 1.00 |
| Cancer | associated_with | disease | 1.00 |
| OVERVIEW | therapeutic_target | gene | 1.00 |
| CANCER | associated_with | gene | 1.00 |
| Als | regulates | disease | 1.00 |
| CANCER | regulates | gene | 1.00 |
| Cancer | regulates | disease | 1.00 |
| Autoimmune | therapeutic_target | disease | 1.00 |
| Cancer | treats | disease | 1.00 |
| FERROPTOSIS | therapeutic_target | gene | 1.00 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 1.00 |
| Alzheimer | therapeutic_target | disease | 1.00 |
| CANCER | treats | gene | 1.00 |
| ALZHEIMER | therapeutic_target | gene | 1.00 |
| PD-L1 | regulates | protein | 0.90 |
| GENES | regulates | gene | 0.90 |
| Alzheimer | associated_with | disease | 0.90 |
| INFLAMMATION | associated_with | gene | 0.90 |
| Inflammation | associated_with | disease | 0.90 |
| ALZHEIMER | associated_with | gene | 0.90 |
| STAT3 | therapeutic_target | gene | 0.90 |
| Lung Cancer | therapeutic_target | disease | 0.90 |
| Aging | therapeutic_target | disease | 0.90 |
| CD8 | therapeutic_target | gene | 0.90 |
| Inflammation | activates | disease | 0.90 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| TFUS-Gamma Entrainment Synergizes with Anti-Amyloid Immunoth | 0.480 | Alzheimer's disease | Closed-loop transcranial focused ultraso |
| Network-Directed Anti-Amyloid Immunotherapy via Transcranial | 0.353 | connectomics | Human connectome alterations in Alzheime |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning Immunotherapy in their description or question text
No additional research found